USD $1.00-1.00 / Kilogram
USD $1.00-1.00 / Kilogram
USD $1.00-1.00 / Kilogram
USD $1.00-1.00 / Kilogram
USD $1.00-1.00 / Kilogram
USD $1.00-1.00 / Kilogram
USD $1.00-1.00 / Kilogram
USD $1.00-1.00 / Kilogram
USD $1.00-1.00 / Kilogram
product name: | levetiracetam |
synonyms: | keppra;levetiracetam;sib-s1;(s)-2-(2-oxopyrrolidin-1-yl)butanamide;ucb-l059;(s)-1-pyrrolidineacetamid;(s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide;levetiracetin(usp24) |
cas: | 102767-28-2 |
mf: | c8h14n2o2 |
mw: | 170.21 |
einecs: | 200-659-6 |
product categories: | anticonvulsant;intermediates & fine chemicals;pharmaceuticals;miscellaneous compounds;amines;chiral reagents;heterocycles;nootropic;smart drug;pharmaceutical raw material;api;other apis |
mol file: | 102767-28-2.mol |
levetiracetam chemical properties |
melting point | 118-119°c |
alpha | -89.7 º |
storage temp. | store at rt |
cas database reference | 102767-28-2(cas database reference) |
safety information |
hazard codes | xn,t,f |
risk statements | 22-36-39/23/24/25-23/24/25-11 |
safety statements | 26-45-36/37-16-7 |
rtecs | ux9656166 |
hazardous substances data | 102767-28-2(hazardous substances data) |
msds information |
provider | language |
---|---|
levetiracetam | english |
levetiracetam usage and synthesis |
chemical properties | white crystalline solid |
usage | the (s)-enantiomer of the ethyl analog of piracetam. used as an anticonvulsant. |
usage | the (s)-enantiomer of etiracetam (e932970) and the ethyl analog of piracetam (p500800). used as an anticonvulsant. |
usage | a compound which inhibits burst firing without affecting normal neuronal excitability |
usage | used as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy. |
definition | chebi: a pyrrolidinone and carboxamide that is n-methylpyrrolidin-2-one in which one of the methyl hydrogens is replaced by an aminocarbonyl group, while another is replaced by an ethyl group (the s enantiomer). an anticonvulsa t, it is used for the treatment of epilepsy in both human and veterinary medicine. |
biological activity | antiepileptic that displays distinctive properties from conventional antiepileptic drugs. displays potent seizure protection in animal models of chronic epilepsy but lacks activity in acute seizure models. binds synaptic vesicle protein 2a (sv2a) and inhibits na + -dependent cl - /hco 3 - exchange. |